Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Mark it with a pen
Key Takeaways AOD 9604 produces 2-3 times greater fat loss than placebo in clinical trials with women Standard dosing ranges from 0.5mg to 1mg daily via subcutaneous injection Side effects occur in fewer than 5% of women, primarily mild injection site reactions Results typically become visible after 4-6 weeks of consistent daily administration The peptide preserves lean muscle mass while specifically targeting fat tissue How AOD 9604 Works for Female Fat Loss AOD 9604 functions by activating beta-3 adrenergic receptors in adipose tissue, specifically triggering lipolysis without the growth-promoting effects of full-length growth hormone
Canadian Cold-Chain Storage Protocols Strict adherence to climate-controlled, cold-chain storage is mandatory to preserve the structural integrity of the amino acid sequence
Essential practices include cleaning the injection site with alcohol swabs and allowing to dry, using new sterile needles for each injection, swabbing vial rubber stoppers before each draw, avoiding touching needle tips to any surface, and disposing of needles properly in sharps containers
BAC Water 3ML is a standalone support item, not an active research compound, and is offered for convenience next to the rest of the catalog
The World Anti-Doping Agency (WADA) does not currently list GLP-1 receptor agonists as prohibited substances
